FRIDAY - NOVEMBER 1ST

• Sarah H. Kagan PhD, RN, GCNS-BC, AOCN, FAAN, FGSA - University of Pennsylvania

PCS: Unlocking Secrets: Hidden Gems and Clinical Pearls - Symptom Management

• Moderated by Sarah H. Kagan PhD, RN, GCNS-BC, AOCN, FAAN, FGSA - University of Pennsylvania
• Germine Soliman, MD - UConn Health
• Cosmina Fachiol, MD - Northern Light Eastern Maine Medical Center
• Molly Bacon, PharmD - Dana-Farber Cancer Institute
• Jon Jehle, NP, ACHPN - Brigham and Women’s Hospital

Networking & Exhibits - Door Prize: Anker Power Bank

Presidential Wing

PCS: Unlocking Secrets: Hidden Gems and Clinical Pearls - Symptom Management (part 2)

• Moderated by Sarah H. Kagan PhD, RN, GCNS-BC, AOCN, FAAN, FGSA - University of Pennsylvania
• Germine Soliman, MD - UConn Health
• Cosmina Fachiol, MD - Northern Light Eastern Maine Medical Center
• Molly Bacon, PharmD - Dana-Farber Cancer Institute
• Jon Jehle, NP, ACHPN - Brigham and Women’s Hospital

Grand Ballroom

 Lunch & Exhibits

Annual Meeting Welcome

Drivers of Health in Northern New England - Community Context Driving Cancer Outcomes

• Sally Kraft, MD, MPH - Dartmouth Health
• Andrew P. Loehrer, MD, MPH - Dartmouth Health

This session will discuss and describe drivers of cancer inequity and disparities in New England rural populations, exploring opportunities for providers and health systems to improve equity. 

Advancing Access and Equity in Hematology: Addressing Barriers to Care Through Patient Navigation and Multidisciplinary Care

• Facilitated by Ludmila Svoboda, RN, BSN, MA, MSN, OCN - Dana-Farber Cancer Institute
• Paula Aguilera, RN - Dana Farber Cancer Institute
• Kidest Mequanent, MHA - Dana-Farber Cancer Institute
• Manisha Fleurisme, Patient Navigator
• Lachelle Weeks, MD, PhD - Dana-Farber Cancer Institute
• Julio A. Toro, RN - Dana-Farber Cancer Institute

This session will explore the importance of assessing patients’ Social Determinants of Health, identifying barriers to care both urban and rural patients face. We'll identify the role of Patient Navigators and discuss why historically marginalized patients are often reluctant to participate in clinical trials. 

Presidential Wing

Breakout Sessions:

Putting the “Person” in “Personalized Medicine”

• Jens Rueter, MD - The Jackson Laboratory
• Christine Walko, PharmD - Moffitt Cancer Center

Dr. Reuter will provide an overview of the Maine Cancer Genomics Initiative, including a history of the initiative, present day, and future plans. Afterwards, Dr. Walko will present on the precision oncology program at Moffitt Cancer Center.

In the latter half of the session, Dr. Walko will discuss Tumor-agnostic drug approvals targeting BRAF, and Dr. Reuters will share information on the trastuzumab deruxtecan approval and data on the drug’s efficacy in various tumor types.

3:25-3:35:Q&A

3:35-3:45:Histology Agnostic Approvals (BRAF) (Chris Walko)

3:55-4:05: Q&A

The Value of Cancer Rehabilitation across the Cancer Journey

• Teresa Fitzpatrick, PT, MBA

Researchers show that 60-90% of cancer survivors experience functional decline. These declines are associated with diminished ability to receive treatment, high health care utilization, and poor quality of life. Rehabilitation services provided by cancer-specialized physical and occupational therapists can help by treating patient’s functional needs. Growing research evidence shows that starting rehabilitation services early in the cancer journey can help to mitigate, or even prevent, functional decline and may be key to helping patients stay on treatment and recover afterward. In this presentation, we will discuss the value of cancer rehabilitation across the treatment continuum through multiple lenses, including research evidence, patient reports, and oncology provider experiences.

 Presidential Wing

• Jennifer J. Kelly, DO - University of Vermont Medical Center

Practical elements of bone health preservation will be discussed including DXA screening and interpretation, along with the proper use of medications to prevent fractures with a focus on patients undergoing treatment for cancer.

Conservatory & Grand Foyer

Dinner Program & Podium Presentations:

• Viral Hepatitis Screening Prior to Initiation of Immunosuppressive Agents for Treatment of Oncologic and Hematologic Malignancies - Margaret Gray, MD - University of Vermont Medical Center
  
  
• Neoadjuvant Aromatase Inhibitor Therapy for ER+ Breast Cancer, the NAOMI trial - Marie Anne Christine Buteau, MD - Dartmouth-Hitchock Medical Center
  
  
• Risk Factors for Venous Thrombosis after Discharge from Medical Hospitalizations: The Medical Inpatient Thrombosis and Hemostasis (MITH) Study - Ryan Thomas, MD - University of Vermont Medical Center

Grand Ballroom

S'mores Reception